Bliss GVS Pharma - Quaterly Results

01 Aug 2023 Evaluate
Net sales declined -26.00%  to  Rs. 1089.92 million from Rs. 1472.80 millions.Profit after Tax for the quarter ended June 2023 saw a decline of -69.58% from Rs. 246.44 millions to Rs. 74.96  millions.A decline of 175.78 millions was observed in the OP in the quarter ended June 2023 from 377.81 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 1089.92 1472.80 -26.00 1089.92 1472.80 -26.00 5983.40 6363.57 -5.97
Other Income 65.27 186.34 -64.97 65.27 186.34 -64.97 507.66 326.28 55.59
PBIDT 175.78 377.81 -53.47 175.78 377.81 -53.47 1409.21 1418.26 -0.64
Interest 13.09 20.42 -35.90 13.09 20.42 -35.90 100.57 43.24 132.59
PBDT 162.69 357.39 -54.48 162.69 357.39 -54.48 1308.64 1402.47 -6.69
Depreciation 53.64 36.74 46.00 53.64 36.74 46.00 151.73 138.47 9.58
PBT 109.05 320.65 -65.99 109.05 320.65 -65.99 1156.91 1264.00 -8.47
TAX 34.09 74.21 -54.06 34.09 74.21 -54.06 302.14 337.36 -10.44
Deferred Tax 7.00 -12.25 -157.14 7.00 -12.25 -157.14 -42.10 7.68 -648.18
PAT 74.96 246.44 -69.58 74.96 246.44 -69.58 854.77 926.64 -7.76
Equity 104.22 103.81 0.39 104.22 103.81 0.39 104.15 103.68 0.45
PBIDTM(%) 16.13 25.65 -37.13 16.13 25.65 -37.13 23.55 22.29 5.68

Bliss GVS Pharma Share Price

166.60 -9.20 (-5.23%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×